Healthcare Baxter gets USFDA warning letter on recently acquired Claris plant Updated : July 19, 2018 01:29 PM IST In June and July 2010, Claris’s facility in Ahmedabad and the US facility located at New Jersey was inspected by the USFDA. Baxter-Claris announced the deal on July 27, 2017, and the same day the USFDA started their re-inspection of the Ahmedabad facility. Subscribe to Moneycontrol PRO at just Rs.33/- per month for the first year. Use code SUPERPRO. Limited period offer. Available on Web and Android.